Associate Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine
Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
Dr. Rebecca Silbermann is an Associate Professor of Medicine at the Knight Cancer Institute, Oregon Health & Science University, where she leads the multiple myeloma research program and cares for myeloma and amyloidosis patients in the clinic. She is particularly interested in myeloma bone disease and preservation of function in elderly myeloma patients. Her clinical research program focuses on novel drug targets and drug combinations for patients with relapsed and refractory multiple myeloma. She completed her hematology and medical oncology training at the University of Pittsburgh and previously served on the faculty at the University of Pittsburgh and Indiana University before moving to OHSU in 2017.